Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Protein kinase C inhibitors induce apoptosis in human malignant glioma cell lines.

Couldwell WT, Hinton DR, He S, Chen TC, Sebat I, Weiss MH, Law RE.

FEBS Lett. 1994 May 23;345(1):43-6.

2.

Growth inhibition and apoptosis in human neuroblastoma SK-N-SH cells induced by hypericin, a potent inhibitor of protein kinase C.

Zhang W, Lawa RE, Hintona DR, Su Y, Couldwell WT.

Cancer Lett. 1995 Sep 4;96(1):31-5.

PMID:
7553605
3.

Protein kinase C inhibitors suppress cell growth in established and low-passage glioma cell lines. A comparison between staurosporine and tamoxifen.

Baltuch GH, Couldwell WT, Villemure JG, Yong VW.

Neurosurgery. 1993 Sep;33(3):495-501; discussion 501.

PMID:
8413883
4.

Combination therapy with irinotecan and protein kinase C inhibitors in malignant glioma.

Chen TC, Su S, Fry D, Liebes L.

Cancer. 2003 May 1;97(9 Suppl):2363-73.

6.

Staurosporine differentially inhibits glioma versus non-glioma cell lines.

Baltuch GH, Dooley NP, Couldwell WT, Yong VW.

J Neurooncol. 1993 May;16(2):141-7.

PMID:
8289091
7.

Lovastatin induces growth inhibition and apoptosis in human malignant glioma cells.

Jones KD, Couldwell WT, Hinton DR, Su Y, He S, Anker L, Law RE.

Biochem Biophys Res Commun. 1994 Dec 30;205(3):1681-7.

PMID:
7811252
8.

Tamoxifen-induced growth arrest and apoptosis in pituitary tumor cells in vitro via a protein kinase C-independent pathway.

Simard M, Zhang W, Hinton DR, Chen TC, Weiss MH, Su YZ, Gopalakrishna R, Law RE, Couldwell WT.

Cancer Lett. 2002 Nov 28;185(2):131-8.

PMID:
12169386
9.

Hypericin-induced apoptosis of human malignant glioma cells is light-dependent, independent of bcl-2 expression, and does not require wild-type p53.

Weller M, Trepel M, Grimmel C, Schabet M, Bremen D, Krajewski S, Reed JC.

Neurol Res. 1997 Oct;19(5):459-70.

PMID:
9329022
10.

Effect of tamoxifen on DNA synthesis and proliferation of human malignant glioma lines in vitro.

Pollack IF, Randall MS, Kristofik MP, Kelly RH, Selker RG, Vertosick FT Jr.

Cancer Res. 1990 Nov 15;50(22):7134-8.

11.

Paradoxical elevation of Ki-67 labeling with protein kinase inhibition in malignant gliomas.

Couldwell WT, Weiss MH, Law RE, Hinton DR.

J Neurosurg. 1995 Mar;82(3):461-8.

PMID:
7861225
14.

Enhanced protein kinase C activity correlates with the growth rate of malignant gliomas in vitro.

Couldwell WT, Uhm JH, Antel JP, Yong VW.

Neurosurgery. 1991 Dec;29(6):880-6; discussion 886-7.

PMID:
1758601
15.

Hypericin: a potential antiglioma therapy.

Couldwell WT, Gopalakrishna R, Hinton DR, He S, Weiss MH, Law RE, Apuzzo ML, Law RE.

Neurosurgery. 1994 Oct;35(4):705-9; discussion 709-10. Erratum in: Neurosurgery 1994 Nov;35(5):993.

PMID:
7808614
16.

Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells.

Hui AM, Zhang W, Chen W, Xi D, Purow B, Friedman GC, Fine HA.

Cancer Res. 2004 Dec 15;64(24):9115-23.

17.
18.

Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinase.

Begemann M, Kashimawo SA, Lunn RM, Delohery T, Choi YJ, Kim S, Heitjan DF, Santella RM, Schiff PB, Bruce JN, Weinstein IB.

Anticancer Res. 1998 Sep-Oct;18(5A):3139-52.

PMID:
9858877
19.

Protein kinase C and growth regulation of pituitary adenomas.

Couldwell WT, Law RE, Hinton DR, Gopalakrishna R, Yong VW, Weiss MH.

Acta Neurochir Suppl. 1996;65:22-6.

PMID:
8738488
20.

Coadministration of sorafenib with rottlerin potently inhibits cell proliferation and migration in human malignant glioma cells.

Jane EP, Premkumar DR, Pollack IF.

J Pharmacol Exp Ther. 2006 Dec;319(3):1070-80. Epub 2006 Sep 7.

Items per page

Supplemental Content

Write to the Help Desk